AbbVie logo

Other

AbbVie·Balance Sheet Statement·23 metrics

Breakdown

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Indefinite- lived intangible impairment$91.4B$99.7B$94.9B$95.3B$95.8B$94.8B$94.9B$94.8B
Gross Carrying Amount$89.8B$90.0B$89.7B$90.0B$90.5B$89.5B$89.6B$89.5B
Long-Term Debt and Lease Obligation$58.0B$58.5B$60.3B$64.5B$63.0B$63.0B$58.9B$64.5B
Finite-Lived Intangible Assets, Accumulated Amortization$31.1B$33.1B$34.9B$36.8B$38.8B$40.4B$42.2B$43.9B
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value$21.7B$22.7B$25.4B$27.0B
Cumulative Cost Basis$11.9B$12.3B$12.3B$12.6B$12.9B$13.2B$13.5B$13.7B
Less: current maturities$12.6B$12.6B$6.8B$3.8B$2.0B$2.0B$6.1B$8.3B
Trademarks$1.6B$9.7B$5.2B$5.3B$5.3B$5.3B$5.3B$5.3B
Common stock, shares authorized (in shares)4B4B4B4B4B4B4B4B
Deferred income taxes$2.7B$2.7B$2.6B$2.6B$2.6B$2.5B$2.4B$2.3B
Common stock, shares issued (in shares)1.8B1.8B1.8B1.8B1.8B1.8B1.8B1.8B
Share Repurchase Program, Remaining Authorized, Amount$3.9B$3.9B$2.9B$2.9B$2.9B$1.8B
Estimated litigation liability$2.4B$2.5B$1.8B$1.8B$1.5B$1.6B$1.7B
Gross Assets/Liabilities$341.0M$446.0M$266.0M$252.0M$880.0M$690.0M$540.0M$338.0M
Derivatives, gross, liabilities$341.0M$446.0M$266.0M$252.0M$880.0M$690.0M$540.0M$338.0M
Trading securities, cost$160.0M$153.0M$169.0M$157.0M$166.0M$172.0M$159.0M$163.0M
Derivative, gross, assets$192.0M$44.0M$313.0M$130.0M$101.0M$125.0M$91.0M$155.0M
Treasury stock, shares (in shares)64.3M64.3M66.3M70.8M70.8M70.8M70.8M77.1M
Noncontrolling interests in subsidiaries$43.0M$39.0M$39.0M$42.0M$45.0M$43.0M$42.0M$44.0M
Pre-tax gains (losses) to be transferred into interest expense, net for treasury rate lock agreement cash flow hedges during the next 12 months$21.0M$21.0M$21.0M$23.0M
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)$105.0M-$8.0M-$36.0M$1.0M
Common stock, par value (in dollars per share)$0.01$0.01$0.01$0.01$0.01$0.01$0.01$0.01
Current maturities of long-term debt$17.0M$19.0M

Metrics

AOCI - Cash Flow Hedge Reclassification (Next 12 Months)

View metric

Cumulative Cost Basis

View metric

Gross Assets/Liabilities

View metric

Common stock, par value (in dollars per share)

View metric

Common stock, shares authorized (in shares)

View metric

Common stock, shares issued (in shares)

View metric

Deferred income taxes

View metric

Derivative, gross, assets

View metric

Derivatives, gross, liabilities

View metric

Trading securities, cost

View metric

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value

View metric

Current maturities of long-term debt

View metric

Finite-Lived Intangible Assets, Accumulated Amortization

View metric

Gross Carrying Amount

View metric

Trademarks

View metric

Indefinite- lived intangible impairment

View metric

Estimated litigation liability

View metric

Long-Term Debt and Lease Obligation

View metric

Less: current maturities

View metric

Noncontrolling interests in subsidiaries

View metric

Share Repurchase Program, Remaining Authorized, Amount

View metric

Pre-tax gains (losses) to be transferred into interest expense, net for treasury rate lock agreement cash flow hedges during the next 12 months

View metric

Treasury stock, shares (in shares)

View metric